MetaTOC stay on top of your field, easily

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety

, ,

Therapeutic Advances in Gastroenterology

Published online on

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.